Livanova Plc (LIVN): Daniel Jeffrey Moore , director of Livanova Plc sold 1,000 shares on Apr 15, 2016. The Insider selling transaction was reported by the company on Apr 19, 2016 to the Securities and Exchange Commission. The shares were sold at $54.81 per share for a total value of $54,807.60 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 17, 2016, Daniel Jeffrey Moore (director) sold 1,000 shares at $56.88 per share price.
Currently the company Insiders own 3.97% of LivaNova PLC shares according to the proxy statements.Institutional Investors own 68.9% of LivaNova PLC shares.During last six month period, the net percent change held by insiders has seen a change of -2.75%.
LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management Cardiac Surgery and Neuromodulation. The Company provides solutions for patients healthcare professionals and healthcare systems. The Company’s Cardiac Rhythm Management unit focuses on Bradyarrhythmia Tachyarrhythmia Heart Failure Arrhythmia Assessment and Electrophysiology. The Company’s Cardiac Surgery unit focuses on Aortic Mitral Perfusion Cannulae Minimally Invasive Cardiac Surgery and Pediatric. Its Neuromodulation unit focuses on providing medical device solutions for people affected by treatment-resistant epilepsy depression heart failure and other chronic disorders. Its products include PARADYM RF VOLTA SMARTVIEW SOLO SMART CONNECT INSPIRE XTRA MINIMALLY INVASIVE CARDIAC SURGERY CANNULAE and PEDIATRIC CANNULAE among others.